Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences

Director
Telephone: 412-586-9771

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

University of Pittsburgh Schools of the Health Sciences

​Renowned Cancer Researcher to Discuss Basis of Tumor Development at 2007 Bernard Fisher Lecture

PITTSBURGH, February 13, 2007 Robert A. Weinberg, Ph.D., whose groundbreaking research led to the first isolation of a gene that prompts normal healthy cells to develop into malignancies, will deliver the 2007 Bernard Fisher Lecture, named in honor of University of Pittsburgh pioneering breast cancer researcher, Bernard Fisher, M.D., at 3:30 p.m., Wednesday, Feb. 28.

Dr. Weinberg, a Pittsburgh native who is the Daniel K. Ludwig Professor of Biology at the Massachusetts Institute of Technology (MIT), will speak in Auditorium 6, Scaife Hall, 3550 Terrace St., on Pitts Oakland campus. His topic will be Mechanisms Leading to the Formation of Human Tumors. The event is free and open to the public, and a reception will follow the lecture in Room 1105, Scaife Hall.

Dr. Weinberg's remarkable career has helped elucidate some of the most fundamental issues regarding the genetic causes of cancer and the mechanisms of metastasis, said Arthur S. Levine, M.D., senior vice chancellor for the health sciences and dean of the School of Medicine. His visit will be a most fitting tribute to Dr. Fisher, whose research contributions involving breast cancer and its metastatic nature have achieved iconic stature.

Most widely known for leading the efforts that isolated the first human oncogenea gene that can cause normal cells to form tumors and the first known tumor suppressor gene, Dr. Weinberg has focused his current research on human cancer cells ability to invade nearby tissues and disperse to distant sites in the body, generating metastases there. His lab has determined that tumor cells metastasize by awakening genes that are normally dormant after embryogenesis. Metastasis is a particularly important subject for study because 90 percent of cancer deaths occur as a result of metastasis rather than the original, primary tumor.

Dr. Weinberg, also a founding member of the Whitehead Institute for Biomedical Research, recently was named head of MITs new Ludwig Center for Molecular Oncology, which will focus on the biology of cancer metastasis. He completed his undergraduate and doctoral work in biology at MIT, where he has been a professor of biology since 1982, the same year in which he was named Discover magazines Scientist of the Year. Dr. Weinberg is a winner of the National Medal of Science, a member of the National Academy of Sciences and the Institute of Medicine, and a fellow of the American Academy of Arts and Sciences.

Lecture namesake Dr. Fisher, a 1943 graduate of Pitts medical school, is a distinguished service professor of surgery at the school. He also is past chairman and scientific director of the Pittsburgh-based research consortium known as the National Surgical Adjuvant Breast and Bowel Project, which, in the late 1960s, found radical mastectomy to be no more effective than total mastectomy and, in turn, total mastectomy to be no more effective than lumpectomy in treating breast cancer. In 1990, Dr. Fishers group went on to show the effectiveness of adjuvant chemotherapy and hormonal therapy (tamoxifen) in treating breast cancer as a systemic disease, not one that could be cured by surgery alone. In subsequent studies, he found that tamoxifen substantially reduces the incidence of breast cancer in high-risk women, providing evidence that breast cancer can be both treated and prevented.

Dr. Fishers many honors and awards include the Albert Lasker Clinical Medical Research Award, the General Motors Cancer Research Foundations Kettering Prize, the Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, the American Cancer Society Medal of Honor and the American Surgical Association Medallion for Scientific Achievement.

 

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com